The Transcatheter Cardiovascular Therapeutics (TCT) conference is the world’s largest and most important educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center of cutting-edge educational content, showcasing the latest advances in current therapies and clinical research. TCT provides the latest evidence-based data, presented by leading physicians, nurses, and scientists, that will affect the practice of interventional cardiology and endovascular medicine.
The 2017 conference featured some of the most influential cardiovascular business leaders in the world, and DRG’s renowned analysts were in attendance in order to bring the most updated insight to our business partners.
Take a moment to review our analysts’ recap of the event, as told by those who attended and shared their experiences live via social media.